Health technology assessment related to drugs and medical devices across several disease areas (cardio-vascular system, stroke, oncology, orthopedics) using various methodological approaches: 1-Systematic review and evidence synthesis methods (including indirect and mixed treatment comparisons) 2-Clinical research 3-Cost-effectiveness using modelling approaches or economic evaluations alongside clinical trials 4-Epidemiology of clinical practices and outcome research using real-world evidence

I graduated in pharmacy (PharmD) from the University Claude Bernard Lyon 1 (France) in 2004. After completing an MSc in Health Service Research, I started a PhD program at the University Henri Poincare (Nancy, France) that I gained in 2007. I then started to work as pharmacist in the department of innovation from the Division of Clinical Research and Innovation of Lyon University Hospitals. Within this department, my work consisted of screening innovative Health technologies using medical devices and drugs, undertaking hospital-based health technology assessment, writing clinical research protocols submitted to national calls. In order to gain a broader experience on Health technology assessment within the UK perspective, I joined the Warwick Evidence team (University of Warwick) in August 2015 for a visting fellowship then I had the opportunity to continue my experience in the UK being appointed senior research fellow with Warwick Evidence. Late 2016, I gained the French accreditation to supervise research ("habilitation à diriger des recherches") degree from the Claude Bernard Lyon 1 university in France.